237 related articles for article (PubMed ID: 24628514)
1. Review article: the investigation and management of gastric neuroendocrine tumours.
Basuroy R; Srirajaskanthan R; Prachalias A; Quaglia A; Ramage JK
Aliment Pharmacol Ther; 2014 May; 39(10):1071-84. PubMed ID: 24628514
[TBL] [Abstract][Full Text] [Related]
2. Review article: the investigation and management of rectal neuroendocrine tumours.
Basuroy R; Haji A; Ramage JK; Quaglia A; Srirajaskanthan R
Aliment Pharmacol Ther; 2016 Aug; 44(4):332-45. PubMed ID: 27302838
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and treatment of gastric neuroendocrine tumours.
Plöckinger U
Wien Klin Wochenschr; 2007; 119(19-20):570-2. PubMed ID: 17985089
[TBL] [Abstract][Full Text] [Related]
4. Gastric Neuroendocrine Tumors (Carcinoids).
Gluckman CR; Metz DC
Curr Gastroenterol Rep; 2019 Mar; 21(4):13. PubMed ID: 30868284
[TBL] [Abstract][Full Text] [Related]
5. Management of gastric and duodenal neuroendocrine tumors.
Sato Y; Hashimoto S; Mizuno K; Takeuchi M; Terai S
World J Gastroenterol; 2016 Aug; 22(30):6817-28. PubMed ID: 27570419
[TBL] [Abstract][Full Text] [Related]
6. [Hyperplastic polyp with neoplastic transformation in a patient with atrophic gastritis and multiple gastric neuroendocrine tumors].
Moura EG; Domingos TA; Alvarado H; Iriya K; Kishi HS; Martins BC; Moura ET; P PS
Rev Gastroenterol Mex; 2012; 77(2):96-8. PubMed ID: 22658549
[TBL] [Abstract][Full Text] [Related]
7. Systematic review: management of localised low-grade upper gastrointestinal neuroendocrine tumours.
Exarchou K; Howes N; Pritchard DM
Aliment Pharmacol Ther; 2020 Jun; 51(12):1247-1267. PubMed ID: 32390152
[TBL] [Abstract][Full Text] [Related]
8. Gastric Carcinoids.
Grozinsky-Glasberg S; Alexandraki KI; Angelousi A; Chatzellis E; Sougioultzis S; Kaltsas G
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):645-660. PubMed ID: 30098721
[TBL] [Abstract][Full Text] [Related]
9. Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study.
Campana D; Ravizza D; Ferolla P; Faggiano A; Grimaldi F; Albertelli M; Berretti D; Castellani D; Cacciari G; Fazio N; Colao A; Ferone D; Tomassetti P
Endocrine; 2016 Jan; 51(1):131-9. PubMed ID: 25814125
[TBL] [Abstract][Full Text] [Related]
10. Gastric neuroendocrine tumours.
Crosby DA; Donohoe CL; Fitzgerald L; Muldoon C; Hayes B; O'Toole D; Reynolds JV
Dig Surg; 2012; 29(4):331-48. PubMed ID: 23075625
[TBL] [Abstract][Full Text] [Related]
11. Netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis.
Moore AR; Boyce M; Steele IA; Campbell F; Varro A; Pritchard DM
PLoS One; 2013; 8(10):e76462. PubMed ID: 24098507
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours.
Min BH; Hong M; Lee JH; Rhee PL; Sohn TS; Kim S; Kim KM; Kim JJ
Br J Surg; 2018 Oct; 105(11):1480-1486. PubMed ID: 29893418
[TBL] [Abstract][Full Text] [Related]
13. Gastric and duodenal neuroendocrine tumours.
O'Toole D; Delle Fave G; Jensen RT
Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):719-35. PubMed ID: 23582915
[TBL] [Abstract][Full Text] [Related]
14. Correlation between a short-term intravenous octreotide suppression test and response to antrectomy in patients with type-1 gastric neuroendocrine tumours.
Murugesan SV; Steele IA; Dimaline R; Poston GJ; Shrotri M; Campbell F; Varro A; Pritchard DM
Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):474-81. PubMed ID: 23249603
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine neoplasms of the stomach.
Louthan O
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):455-60. PubMed ID: 23817299
[TBL] [Abstract][Full Text] [Related]
16. Gastric neuroendocrine neoplasms.
Lamberti G; Panzuto F; Pavel M; O'Toole D; Ambrosini V; Falconi M; Garcia-Carbonero R; Riechelmann RP; Rindi G; Campana D
Nat Rev Dis Primers; 2024 Apr; 10(1):25. PubMed ID: 38605021
[TBL] [Abstract][Full Text] [Related]
17. Gastric Neuroendocrine Tumor and Duodenal Gastrinoma With Chronic Autoimmune Atrophic Gastritis.
Chen WC; Warner RRP; Harpaz N; Zhu H; Roayaie S; Kim MK
Pancreas; 2019 Jan; 48(1):131-134. PubMed ID: 30531243
[TBL] [Abstract][Full Text] [Related]
18. [Carcinoid tumors of the stomach in atrophic autoimmune gastritis: classification, differential diagnosis and prognosis].
Rappel S; Rindi G; Bordi C; Capella C; Solcia E; Altendorf-Hofmann A; Stolte M
Verh Dtsch Ges Pathol; 1996; 80():199-207. PubMed ID: 9065002
[TBL] [Abstract][Full Text] [Related]
19. Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study.
Campana D; Ravizza D; Ferolla P; Faggiano A; Grimaldi F; Albertelli M; Ricci C; Santini D; Brighi N; Fazio N; Colao A; Ferone D; Tomassetti P
Endocrine; 2017 Jun; 56(3):633-638. PubMed ID: 27592118
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of endoscopic resection for type I gastric neuroendocrine tumors.
Uygun A; Kadayifci A; Polat Z; Yilmaz K; Gunal A; Demir H; Bagci S
J Surg Oncol; 2014 Feb; 109(2):71-4. PubMed ID: 24165913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]